Nasdaq-listed biotech firm Sonnet BioTherapeutics announced Monday a $888 million merger agreement with Rorschach I LLC, an ...

Sonnet BioTherapeutics enters into an agreement to transform into the largest U.S.-based publicly listed company to hold HYPE ...

Sonnet BioTherapeutics (NASDAQ:SONN) saw its stock soar by 290% after announcing an $888 million business combination that will pivot the company into a cryptocurrency treasury focused on HYPE tokens.

Combined company expected to become largest U.S.-based publicly listed company to hold HYPE in its treasuryPRINCETON, N.J., July 14, 2025 ( ...

Hyperliquid (HYPE) trades near $48 on Monday following Sonnet BioTherapeutics' (SONN) announcement that it has entered a ...

Sonnet to merge with crypto-backed firm, forming Hyperliquid Strategies with $888 million in assets, plus HYPE blockchain ...

Sonnet BioTherapeutics announced an $888 million business combination to create Hyperliquid Strategies Inc, a public ...

Sonnet BioTherapeutics will transform into a new entity called HyperLiquid Strategies at the agreement's close. The new company is expected to hold 12.6 million HYPE tokens and gross cash invested of ...

HYPE rallies toward $50 after Sonnet BioTherapeutics combines with Rorschach to launch a $583 million Hyperliquid token ...

Sonnet BioTherapeutics pivots to crypto with $888M deal, forming Hyperliquid Strategies Inc. to hold 12.6M HYPE tokens.

Sonnet BioTherapeutics Holdings Inc has a consensus price target of $10.18 based on the ratings of 4 analysts. The high is $20 issued by Chardan Capital on April 7, 2025.The low is $6.7 issued by ...